Therapy News and Research

RSS

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the appointment of Paul Johnson as an Independent Non-Executive Director.

From Closed Loop Medicine 22 May 2024

Study reveals low adoption of recommended smart inhaler therapy for asthma

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians have not adopted this optimal therapy, according to research published at the ATS 2024 International Conference.

21 May 2024

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Scientists have used breast cancer cells' weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.

21 May 2024

Understanding the role of oxidative stress in Alzheimer's disease pathogenesis

The number of people suffering from Alzheimer's disease (AD) is expected to reach 100 million by 2050, but there is still no effective therapy.

21 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Exercise enhances efficacy of antibody therapy in leukemia patients

Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.

21 May 2024

Study offers new insights into how ketamine works

A World Health Organization Essential Medicine, ketamine is widely used at varying doses for sedation, pain control, general anesthesia and as a therapy for treatment-resistant depression.

21 May 2024

Can music therapy improve language development in preterm children by 24 months?

The impact of parent-led, infant-directed singing on language development at 24 months.

21 May 2024

Taurine supplementation shows promise in reducing metabolic syndrome risk factors, study finds

A study in Nutrition & Diabetes meta-analyzed randomized clinical trials and found that taurine supplementation significantly reduces key risk factors for metabolic syndrome, such as high blood pressure, fasting blood glucose, and triglycerides, with no notable adverse effects.

20 May 2024

Study uncovers key biological pathways driving psoriasis inflammation

A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds.

20 May 2024

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug - dupilumab - that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.

20 May 2024

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair.

20 May 2024

From research to practice: Closing the divide in obesity management

As research continues to produce evidence about the underlying causes of obesity and optimal strategies to treat and manage obesity have evolved, there are disparities in application of the latest scientific advances in the clinical care that people with obesity receive.

20 May 2024

Internet-based CBT effectively reduces depression and insomnia, study shows

A new study at Hebrew University examined the effects of guided internet-based cognitive behavioral therapy for depression, focusing on the therapeutic alliance and attachment styles.

20 May 2024

Intracellular protein delivery with HyNT stamp system: A leap forward in cancer therapy

The intracellular delivery of proteins is an important technique for unveiling the cellular functions, protein complex structure, and therapeutics. However, the conventional delivery methods have several limitations.

20 May 2024

Study reveals benefits of hormone replacement therapy in female pulmonary hypertension patients

The use of hormone replacement therapy (HRT) may be associated with improved pulmonary hypertension in women, according to research presented at the ATS 2024 International Conference. Pulmonary hypertension (PH) is a type of pulmonary vascular disease - disease that affects blood vessels along the route between the heart and lungs.

20 May 2024

Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models.

20 May 2024

Non-viral gene therapy offers hope for chronic low back pain sufferers

A novel non-viral gene therapy for discogenic back pain (DBP).

20 May 2024

Acetaminophen shows potential in preventing acute respiratory distress syndrome, organ injury in sepsis patients

A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients' risk of having organ injury or developing acute respiratory distress syndrome, a serious condition that allows fluid to leak into the lungs.

20 May 2024

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

A review in Nature Reviews Cancer emphasizes the necessity for cancer researchers to understand AI's potentials and limitations, detailing its applications and challenges in cancer research to aid non-computational biologists.

20 May 2024

Therapy News and Research

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Study reveals low adoption of recommended smart inhaler therapy for asthma

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Understanding the role of oxidative stress in Alzheimer's disease pathogenesis

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Exercise enhances efficacy of antibody therapy in leukemia patients

Study offers new insights into how ketamine works

Can music therapy improve language development in preterm children by 24 months?

Taurine supplementation shows promise in reducing metabolic syndrome risk factors, study finds

Study uncovers key biological pathways driving psoriasis inflammation

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

From research to practice: Closing the divide in obesity management

Internet-based CBT effectively reduces depression and insomnia, study shows

Intracellular protein delivery with HyNT stamp system: A leap forward in cancer therapy

Study reveals benefits of hormone replacement therapy in female pulmonary hypertension patients

Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

Non-viral gene therapy offers hope for chronic low back pain sufferers

Acetaminophen shows potential in preventing acute respiratory distress syndrome, organ injury in sepsis patients

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News